NuVasive, Inc. (NUVA) has a market capitalization of $2.08B and trades at $39.75. The 52-week range is 35.17-49.53.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 51, Earnings Per Share (EPS) of $0.78, annual revenue of $1.2B.
The stock has a beta of 1.07, operates in the Healthcare sector.